GlassScriptPhysician profile
Pandelis Banias
NPI 1558477570
$7,311.58
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,194 · 2020: $2,860 · 2021: $1,258.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $877.43 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $729.03 | 2019-2021 | |
| Glaxosmithkline, LLC. | $648.39 | 2019-2021 | |
| Pfizer INC. | $573.55 | 2019-2021 | |
| Novo Nordisk INC | $540.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $525.33 | 2019-2021 | |
| Lilly USA, LLC | $493.88 | 2019-2021 | |
| Amgen INC. | $308.07 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $281.25 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $273.57 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $269.55 | 2019-2021 | |
| Abbvie INC. | $229.58 | 2020-2021 | |
| Allergan, INC. | $226.25 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.33 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $180.30 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $177.81 | 2019-2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.13 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $80.51 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $66.69 | 2019-2020 | |
| Esperion Therapeutics, INC. | $59.86 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $59.53 | 2019-2020 | |
| Horizon Therapeutics Plc | $54.89 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $48.08 | 2021 | |
| Mylan Specialty L.P. | $44.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $42.22 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $37.52 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $21.12 | 2019 | |
| Eyevance Pharmaceuticals LLC | $14.60 | 2021 | |
| Alfasigma USA, INC. | $14.45 | 2020 | |
| Circassia INC. | $11.32 | 2019 | |
| Mission Pharmacal Company | $10.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pandelis Banias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.